Skip to content

Clinical trials

Phase 2 Anemia trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Anemia Phase: Phase 2 Country / region: China Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20112
20122
20131
20142
20151
20201
20211
20221
20232
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status8
Completed4
Active, not recruiting1
Not yet recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Institute of Hematology & Blood Diseases Hospital, China3
Jiangsu Hansoh Pharmaceutical Co., Ltd.3
Kyntra Bio2
Bristol-Myers Squibb1
Celgene1
Fudan University1
Hansoh BioMedical R&D Company1
Shenzhen Salubris Pharmaceuticals Co., Ltd.1
Sun Yat-sen University1
Xiamen Amoytop Biotech Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Anemia15
Anemia, Hemolytic3
Hematologic Diseases3
Kidney Failure, Chronic3
Anemia, Aplastic2
Bone Marrow Failure Disorders2
Hemoglobinuria2
Hemoglobinuria, Paroxysmal2
Myelodysplastic Syndromes2
Proteinuria2

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.